Skip to main content

$0.040 -0.002 (-4.76%)

High

$0.04

Low

$0.04

Trades

45

Turnover

$43,679

Volume

1,076,056
30 June 2023 at 4:10pm
Register to track ADO and receive email alerts.
Subject
ADO Ann: Final Director's Interest Notice

ADO Ann: Director Retirement - Mr Parker

ADO Ann: Response to ASX Price Query

ADO Ann: Company Presentation

ADO Ann: Company Rebranding

ADO Ann: Changes to Leadership Team

ADO Ann: Quarterly Update and Appendix 4C

ADO Ann: Ceasing to be a Substantial Holder

ADO Ann: Option Exercise

ADO Ann: Change of Director's Interest Notice x3

ADO Ann: Application for quotation of securities - ADO

ADO Ann: Notification of cessation of securities - ADO

ADO Ann: Notice of Exercise of Options

ADO Ann: S&P DJI Announces March 2023 Quarterly Rebalance

ADO Ann: AnteoTech signs Non-Binding MOU with Wyon

ADO Ann: Notification of cessation of securities - ADO

ADO Ann: Application for quotation of securities - ADO

ADO Ann: Company Update

ADO Ann: AnteoTech signs MOU with Trinseo

ADO Ann: Appendix 4D and Interim Financial Report

ADO Ann: Application for quotation of securities - ADO

ADO Ann: Application for quotation of securities - ADO

ADO Ann: Appointment of Chief Marketing Officer

ADO Ann: Advanced Notice Shareholder Briefing

ADO Ann: Quarterly Update and Appendix 4C

ADO Ann: Change of Director's Interest - Revised

ADO Ann: Response to ASX Query

ADO Ann: Change of Director's Interest Notice x6

ADO Ann: s708A Notice

ADO Ann: Application for quotation of securities - ADO

ADO Ann: Notification regarding unquoted securities - ADO

ADO Ann: Notification regarding unquoted securities - ADO

ADO Ann: AnteoTech receives $3.2m R&D Tax Incentive

ADO Ann: Change of Director's Interest Notice

ADO Ann: Results of 2022 Annual General Meeting

ADO Ann: Managing Director AGM Presentation

ADO Ann: Chairman's Address to Shareholders

ADO Ann: European RAT Clinical Trial Halted to Refocus Initiatives

ADO Ann: AnteoTech Strengthens Management team

ADO Ann: Quarterly Update and Appendix 4C

ADO Ann: Investor Webinar Invitation

ADO Ann: Notice of Annual General Meeting / Proxy Form

ADO Ann: Notification regarding unquoted securities - ADO

ADO Ann: Initial Director's Interest Notice

ADO Ann: Ellume Statement

ADO Ann: Appendix 4G and Corporate Governance Statement

ADO Ann: 2022 Annual Report

ADO Ann: FY22 Results Announcement

ADO Ann: Appendix 4E Preliminary Final Report

ADO Ann: Application for quotation of securities - ADO

Register to track ADO and receive email alerts.

Similar Companies

BPH
CTE
GSS
GTG
MEM
OSL
PAL
PIQ